Jacob Jensen

Jacob Jensen is a Research Associate at BioNTech SE since June 2023, with prior experience at CAMP4 Therapeutics as a CNS Co-op and Cygnal Therapeutics as a Chemical Biology Co-op. At Cygnal Therapeutics, Jacob managed compound screening, assisted in proteomics studies, and developed standardization protocols. Additional experience includes serving as a Lab Assistant at Northeastern University, where Jacob contributed to experiments on the Brain-Immuno-Gut reaction, and working as a Fibrosis Co-op at Morphic Therapeutic, conducting live cell assays and creating automated data analysis tools. Jacob holds a degree in Bioengineering with a focus on Cell and Tissue Engineering from Northeastern University.